InflaRx NV (IFRX)
2.505
+0.04
(+1.42%)
USD |
NASDAQ |
May 18, 16:00
2.46
-0.04
(-1.80%)
After-Hours: 17:58
InflaRx Market Cap : 368.97M for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liminatus Pharma, Inc. | 8.262M |
| Oruka Therapeutics, Inc. | 3.522B |
| MapLight Therapeutics, Inc. | 1.204B |
| Kailera Therapeutics, Inc. | 2.539B |
| QIAGEN NV | 6.959B |
Market Cap Related Metrics
| PS Ratio | 2341.74 |
| Price to Book Value | 8.681 |
| Price | 2.505 |
| Earnings Yield | -27.20% |